High Growth Tech Stocks to Watch This October 2024

As global markets navigate a landscape marked by interest rate adjustments and fluctuating economic indicators, the U.S. small-cap indices like the Russell 2000 have shown robust performance, outpacing larger counterparts amid renewed enthusiasm for tech-driven growth prospects. In this dynamic environment, identifying high-growth tech stocks involves looking for companies that demonstrate strong innovation capabilities and resilience in adapting to shifting market conditions.

Top 10 High Growth Tech Companies

Name	Revenue Growth	Earnings Growth	Growth Rating
Clinuvel Pharmaceuticals	22.32%	27.42%	★★★★★★
Sarepta Therapeutics	23.83%	44.09%	★★★★★★
TG Therapeutics	28.39%	43.54%	★★★★★★
eWeLLLtd	26.52%	27.53%	★★★★★★
Scandion Oncology	40.71%	75.34%	★★★★★★
KebNi	34.75%	86.11%	★★★★★★
Mental Health TechnologiesLtd	27.88%	79.61%	★★★★★★
Adveritas	57.98%	144.21%	★★★★★★
Travere Therapeutics	29.24%	70.32%	★★★★★★
UTI	114.97%	134.60%	★★★★★★

Click here to see the full list of 1266 stocks from our High Growth Tech and AI Stocks screener.

Here's a peek at a few of the choices from the screener.

Beijing Wantai Biological Pharmacy Enterprise (SHSE:603392)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a company focused on the development, manufacturing, and distribution of biological products with a market capitalization of CN¥92.58 billion.

Operations: The company is engaged in the development, manufacturing, and distribution of biological products. It operates in various segments contributing to its revenue streams, focusing on innovative health solutions.

Despite a challenging market, Beijing Wantai Biological Pharmacy Enterprise has demonstrated robust revenue growth, with forecasts indicating an annual increase of 49.4%, significantly outpacing the Chinese market's average of 13.5%. This growth is supported by substantial R&D investments, which have been crucial in driving innovation and maintaining competitive advantage in the biotech sector. Additionally, the company has actively repurchased shares over the past year, investing CNY 200.08 million to buy back 0.24% of its stock, signaling confidence in its financial health and future prospects. The firm's earnings are projected to surge by 95.6% annually, reflecting optimism about its profitability trajectory over the coming years despite current unprofitability. These financial maneuvers underscore Beijing Wantai's strategic efforts to bolster shareholder value and reinforce its standing in a rapidly evolving industry landscape where technological advancements and strategic capital allocation play pivotal roles.

• Navigate through the intricacies of Beijing Wantai Biological Pharmacy Enterprise with our comprehensive health report here.

• Gain insights into Beijing Wantai Biological Pharmacy Enterprise's historical performance by reviewing our past performance report.

Wus Printed Circuit (Kunshan) (SZSE:002463)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Wus Printed Circuit (Kunshan) Co., Ltd. specializes in the research, development, design, manufacture, and sale of printed circuit boards in China with a market capitalization of approximately CN¥82.89 billion.

Operations: The company primarily generates revenue from its PCB business, accounting for CN¥10.18 billion, while also having a smaller contribution from house sale income at CN¥3.94 million.

Wus Printed Circuit (Kunshan) has demonstrated substantial growth, with its half-year sales jumping to CNY 5.19 billion from CNY 3.59 billion year-over-year, reflecting a robust demand for its circuit products. This surge in revenue is complemented by a notable increase in net income, which more than doubled to CNY 1.14 billion. The company's commitment to innovation is evident in its R&D investments, crucial for maintaining competitiveness in the fast-evolving tech landscape. Moreover, the recent approval of a new stock option incentive plan underscores their strategy to attract and retain top talent essential for future growth and technological advancements.

• Click here to discover the nuances of Wus Printed Circuit (Kunshan) with our detailed analytical health report.

• Assess Wus Printed Circuit (Kunshan)'s past performance with our detailed historical performance reports.

Quanta Computer (TWSE:2382)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Quanta Computer Inc. is a global manufacturer and seller of notebook computers, serving markets in Asia, the Americas, Europe, and beyond with a market cap of NT$1.23 trillion.

Operations: Quanta Computer generates revenue primarily from its Electronics Sector, which contributes NT$2.50 trillion to its financial performance. The company's operations are focused on the manufacturing and sale of notebook computers across various international markets.

Quanta Computer has recently shown a promising trajectory with its second-quarter sales soaring to TWD 309.95 billion, up from TWD 245.03 billion the previous year, underpinned by robust earnings growth of 44.3% over the past year—surpassing the tech industry's average of 11.9%. This financial vigor is mirrored in their R&D commitment, where expenses are strategically allocated to fuel innovations critical for staying competitive in evolving markets such as AI and cloud computing. Additionally, their recent strategic moves including a $1 billion bond issuance highlight an aggressive approach to financing further expansion and technological advancements. With revenue and earnings forecasted to grow annually at 36.8% and 19.3%, respectively, Quanta is positioning itself strongly within high-tech sectors poised for substantial future growth.

• Unlock comprehensive insights into our analysis of Quanta Computer stock in this health report.

• Examine Quanta Computer's past performance report to understand how it has performed in the past.

Summing It All Up

• Investigate our full lineup of 1266 High Growth Tech and AI Stocks right here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com